Pharmacological Intervention in Diabetic Retinopathy

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if diabetic retinopathy can be treated with prostaglandin analogues, prostaglandin synthesis inhibitors or carbonic anhydrases inhibitors.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Aarhus
• Treatments: Diclofenac; Dorzolamide; Latanoprost; Ophthalmic Solutions; Tetrahydrozoline

Criteria

Inclusion Criteria:

• Diabetes type 1 with moderate diabetic retinopathy/healthy

• Blood pressure < 135/85 mmHg

Exclusion Criteria:

• Eye disease (excluding diabetic retinopathy)

• Allergic

• Kidney disease

• Liver disease

• Severe asthma

• Heart disease

• Hypertension arterial

• Users of drugs that influence the metabolism of the prostaglandins in the carbon dioxide

• Pregnant and breastfeeding women and women who don't use secure contraception

• Persons who can't do without contact lens in the treated eye.